TrialThe Lancet. Microbe2020

Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.

Andreas Diacon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.